Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy
- 1 September 2003
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 64 (3), 1050-1058
- https://doi.org/10.1046/j.1523-1755.2003.00187.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Nucleotide Diversity and Haplotype Structure of the Human Angiotensinogen Gene in Two PopulationsAmerican Journal of Human Genetics, 2002
- ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritisKidney International, 2000
- Angiotensinogen Gene Polymorphism Near Transcription Start Site and Blood PressureHypertension, 1999
- Angiotensinogen gene and essential hypertension in the JapaneseJournal of Hypertension, 1999
- Role of C/A Polymorphism at −20 on the Expression of Human Angiotensinogen GeneHypertension, 1999
- Natural history and risk factors for immunoglobulin a nephropathy in JapanAmerican Journal of Kidney Diseases, 1997
- A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.JCI Insight, 1997
- Is the antiproteinuric effect of ACE inhibition mediated by intereference in the renin-angiotensin system?Kidney International, 1994
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990